Model Medicines
Model Medicines is an AI-first biotechnology company based in San Diego, California, discovering and developing first-in-class small-molecule drugs by targeting fundamental disease mechanisms it calls biological choke points. Its end-to-end GALILEO AI engine spans drug design, target discovery, and preclinical development, supported by specialized models including AmesNet for regulatory-grade toxicology prediction and ChemPrint for chemical property prediction. Lead programs target RdRp Thumb-1 (a conserved allosteric pocket on viral RNA-dependent RNA polymerase) and BRD4, with lead assets MDL-001, a broad-spectrum oral antiviral candidate, and MDL-4102. Surfaced as a portfolio company of 8vc and added to the API Evangelist network. As of this enrichment pass Model Medicines publishes no public API, developer portal, SDK, or documentation surface; its AI platform is used internally for drug discovery.
Index entry only — little beyond a description and a link, and nothing machine-readable enough for an agent to act on without a human reading the site first.
API Evangelist profiles Model Medicines the way a machine reads it — 1 machine-readable artifact, pulled from the provider's own public surface and indexed so a developer, an analyst, or an AI agent can evaluate it against every other provider on the network.
Every provider in the network is reduced to the same set of machine-readable artifacts — OpenAPI contracts, event specifications, GraphQL schemas, runnable collections, pricing and rate-limit signals, security posture, OAuth scopes, and the agent surfaces (MCP servers and skills) that let software drive the API on its own. We profile them because the interface is the part of a company you can actually inspect: it is a truer signal of what a provider does than any marketing page. From those artifacts we compute the Kin Score — Model Medicines scores 10.8/100 (minimal), with a separate agent-readiness read of 0/100 (human only). The full breakdown is below, followed by every artifact we hold — each card links through to its machine-readable definition on apis.io.
Kin Score
This is the API Evangelist rating — a single, repeatable read computed from the artifacts on this page. Green fill is points earned; the red track is points possible, so every bar shows earned-versus-possible at a glance.
Kin Score
How this is scored →scored 2026-07-27 · rubric v0.5
How we profile Model Medicines
Each block below is one kind of artifact we hold for Model Medicines. For each we say what it is and why it earns a place in the profile, then list every one we've indexed — capped at two rows, scroll within the panel for the rest.
Security Posture 1
Authentication, domain security, vulnerability disclosure, and trust-center signals — the evidence that a provider takes security seriously enough to document it. We profile it because you can't govern what you can't see.
Authentication, domain security, vulnerability disclosure, and trust-center signals.
Resources
Every other property we hold for Model Medicines — documentation, portals, status pages, policies, and corporate surface — grouped by the job it does, following the integrator's arc from getting started to running in production.
Access & Security 1
Authentication, authorization, and security posture
Commercial 1
Pricing, plans, and the legal terms of use
Company 1
The organization behind the API
← All providers · Data indexed from github.com/api-evangelist/model-medicines · machine-readable index on apis.io